CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
55.79
-0.70 (-1.24%)
At close: Sep 4, 2026, 4:00 PM EDT
55.40
-0.39 (-0.70%)
Pre-market: Sep 8, 2026, 4:42 AM EDT
CRISPR Therapeutics AG Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, CRISPR Therapeutics AG stock has a consensus rating of "Buy" and an average price target of $87.56. The average 1-year stock price forecast is 56.95% higher than the current stock price, while the lowest is $44 (-21.13%) and the highest is $291 (+421.60%).
Price Target: $87.56 (+56.95%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CRISPR Therapeutics AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 11 | 10 | 9 | 8 |
| Buy | 5 | 4 | 4 | 5 | 4 | 5 |
| Hold | 9 | 9 | 9 | 10 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 27 | 27 | 25 | 25 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $82 | Buy | Maintains | $82 | +46.98% | Sep 1, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $76 | Buy | Maintains | $76 | +36.23% | Aug 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $80 | Buy | Reiterates | $80 | +43.39% | Aug 31, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 29, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $60 | Hold | Maintains | $60 | +7.55% | Aug 28, 2026 |
Financial Forecast
Revenue This Year
40.83M
from 3.51M
Increased by 1,063.30%
Revenue Next Year
156.58M
from 40.83M
Increased by 283.48%
EPS This Year
-4.45
from -6.47
EPS Next Year
-3.50
from -4.45
EPS and Forward PE are based on non-GAAP adjusted numbers.